Variance in expression of receptors for IgG (FcγRs), complement (CR3) and LPS (mCD14) on polymorphonuclear neutrophils (PMNs) 
Introduction
Periodontitis is a chronic infectious disease of the supportive tissues of the teeth characterized by gradual loss of periodontal attachment and alveolar bone. Approximately 10% of the population suffers from the severe form and, if untreated, it may result in tooth loss. The major pathogens associated with periodontitis are Aggregatibacter actinomycetemcomitans (Aa) and Porphyromonas gingivalis (Pg) (1, 2) . In conjunction with the bacterial challenge, an important role in the onset and progression of periodontitis is played by the host immune response (3) . A phagocytic response represents the first barrier to the penetration of bacteria into periodontal tissue (4) . However, in addition to their defensive role, the phagocytes (polymorphonuclear neutrophils [PMNs] and monocytes) may also be responsible for collateral damage to the periodontal tissues, thus the host defense may be at the cost of periodontal attachment and alveolar bone (5, 6) .
One aspect of the host-derived breakdown of periodontal tissues is related to a hyper-reactive trait of PMNs in response to immunoglobulin G (IgG)-opsonized antigens (7, 8, 9) . The nature of this hyper-reactivity might be related either to the geneticallydetermined increased binding capacity of the receptors for IgG (FcγR) on PMNs or to the increased expression levels of Fcγ-receptors.
There are several types of FcγRs identified on phagocytes: FcγRI (CD64), FcγRIIa (CD32) and FcγRIII (CD16) (10) . Previous studies have shown that single-nucleotide polymorphisms, affecting the IgG-binding domain of the genes of FcγRIIa and IIIb, have functional consequences. PMNs from periodontitis patients bearing the more reactive genotype (i.e. FcγRIIa-131H/H and FcγRIIIb-NA1/NA1) show hyper-reactivity in response to stimulation with A. actinomycetemcomitans or P. gingivalis (11, 9) .
Furthermore, periodontitis patients with FcγRIIa-131H/H genotype have more severe periodontal breakdown than the patients with FcγRIIa-131H/R or 131R/R genotype (9, 12, 13, 14) . There are several studies that reported the expression of FcγRs on peripheral PMNs in periodontitis (15, 16) , but a difference of expression levels between patients and controls could not be demonstrated.
In contrast to the PMN, little data exist on the expression of FcγR by monocytes in periodontitis. Nagasawa et al. (17) 
Materials and methods

Study population
We recruited 19 periodontitis patients who were referred to the Department of Periodontology of the Academic Center for Dentistry Amsterdam (ACTA) for diagnosis and treatment of periodontitis. All patients had ≥8 teeth with radiographic bone loss beyond 30% of the root length. Age-, gender-, race-and smoking status-matched controls were selected among subjects registered for restorative dental procedures or who visited the dental school for regular dental check-ups. Control subjects were selected if they were not missing more than one tooth per quadrant (3 rd molar excluded) and if they showed on dental bitewing radiographs <1 year old a distance between the cemento-enamel junction and the alveolar bone crest of <3 mm. Besides their periodontal condition, all participants were otherwise healthy and had not taken any antibiotics during the last 6 months and no medication that could influence the immune response during the last 2 weeks.
All patients were initially screened in the departmental clinic and had agreed to accept the proposed treatment plan. All samples were taken before the start of the periodontal therapy. All subjects were informed verbally and written about the purposes of the study and had signed an informed consent. The Medical Ethical Committee of the Academic Medical Center of the University of Amsterdam approved the study.
Blood sampling
All participants were asked to fast for at least 12 hours before the clinical visit. 
Bacterial sampling
Subgingival microbiological samples were taken from all subjects to determine the presence of the periodontal pathogens A. actinomycetemcomitans and P. gingivalis.
Samples were taken after venous blood collection to avoid possible phagocyte activation.
Sampling, laboratory procedures, and identification of A. actinomycetemcomitans and P. gingivalis were performed as described before (2) .
Flow cytometric analysis
For cell surface staining, citrated whole blood (40 µl) was incubated for 30 min on ice with saturated concentrations (1-10 µg/mL) of the fluorochrome-conjugated antibodies.
CD14-PE (8G3), CD16-FITC (5D2), and CD11b-FITC (B2) were purchased from 
Bacterial stimulation assays
Brain-heart infusion broth enriched with hemin (5 mg/L) and menadione (1 mg/L) was used for the bacterial culturing. A. actinomycetemcomitans Y4 was grown aerobically for 18h at 37°C in humidified 5% CO 2 , whereas P. gingivalis W83 was grown anaerobically (80% N 2 , 10% H 2 , 10% CO 2 ) for 48h at 37°C. The bacterial suspensions were washed, Chapter 3 reduced to an optical density of 1 at 600 nm in HEPES buffer, and stored in aliquots at -
20°C.
Fresh citrated blood (25 µl) was added to a mix containing 55 µl of A.
actinomycetemcomitans-or P. gingivalis-suspension, 4 µg/mL CD14-PE. The mix was incubated for 60 min at room temperature. In the control tubes, whole blood was incubated with HEPES containing no bacteria. After the incubation period, 1 mL of lysis solution was added to the samples, thoroughly mixed and placed on ice for 15 min. The cells were mildly fixed by addition of 1 mL of HEPES containing 0.3% PFA.
The same FACS-settings were used to determine the expression of mCD14 on PMNs and (23).
Statistical analysis
Data analyses were performed with the SPSS package, version 14.0 (SPSS Inc., Chicago, IL, USA). Means ± standard deviations (SD), and frequency distributions were calculated.
Prior to the analyses normal distributions of data were confirmed by Kolmogorov-Smirnov 
Results
Characteristics of the study population. On the basis of the radiographic bone loss criterion (less than 3 mm between the alveolar bone crest and the cemento-enamel junction on all teeth) one control subject was excluded from the analysis. The culturing results revealed that 12 subjects were Aa + , of which 9 periodontitis patients and 3 controls. Nine patients were Pg + , whereas only 1 control tested positive for P. gingivalis (P=0.004, Receptors expression by PMNs and monocytes. The expression of all tested receptors by PMNs was comparable in patients and controls (Fig. 3. 2A-E). Periodontitis patients had a higher percentage of FcγRIII + monocytes and lower monocytic mCD14 expression than controls ( Fig. 3.2E, F) . Overall, the level of mCD14 was inversely correlated with the percentage of FcγRIII + monocytes (r=-0.473, P=0.003). This correlation was not found in Expression of FcγRs and mCD14 on polymorphonuclear neutrophils and monocytes may determine the periodontal infection control subjects (r=-0.124, P=0.624; Fig. 3.3A) , but was strong within periodontitis patients (r=-0.618, P=0.005; Fig. 3.3B ).
In Tables 3.2 gingivalis resulted in activation of PMNs and monocytes. Important to note was that the % change in mCD14-MFI on PMNs and monocytes after P. gingivalis or A.
PMN and monocyte activation in response to
actinomycetemcomitans stimulation did not differ significantly between patients and controls (data not shown).
Expression of FcγRs and mCD14 on polymorphonuclear neutrophils and monocytes may determine the periodontal infection
The % change in mCD14 expression by PMNs induced by A. (Fig. 3.5A, B) .
Discussion
This study was undertaken to investigate expression patterns of some major receptors by phagocytic cells in periodontitis and health to further elucidate susceptibility, infection patterns and biological pathways in this inflammatory condition. On PMNs we found no differences between patients and controls in the expression patterns of the tested receptors.
On monocytes we found also a comparable expression of FcγRI, II, and CR3 in patients and controls. However, an intriguing finding of this study is the heterogeneity of receptor expression levels between individuals. In the general linear models, bacterial infection patterns appeared as a major determinant for expression levels by monocytes. (Fig. 3.4) ; after correcting for periodontal condition and potential confounding factors, the expression of FcγRI monocytes was still decreased in Aa + subjects (Table 3. 3).
One possible explanation for the lower levels of FcγRs on monocytes from Aa increased before therapy in comparison to healthy subjects (30, 31, 32, 33) . The levels of
FcγRs are changed to "healthy" levels due to treatment (33, 34, 35 periodontal tissues, which is largely attributable to the production of proteolytic enzymes (i.e. matrix-metalloproteinases, elastase) and reactive oxygen species (42) . In particular this process is relevant, since hyper-reactive PMNs in periodontitis have been demonstrated by several research groups and several mechanisms have been proposed (7, 43, 8, 9) . The PMNs from Aa + subjects showed a stronger response to both P. gingivalis and A. actinomycetemcomitans (measured by the change in mCD14), further providing evidence for a hyper-reactive trait of the PMNs from A. actinomycetemcomitans-infected subjects, possibly aggravating the periodontal inflammatory reactions in this individuals (7, 8, 9) . This hypothesis may be strengthened by the observations that A.
actinomycetemcomitans induced stronger PMN activation than P. gingivalis (Fig. 3.5A,   B) . A. actinomycetemcomitans might be in general a stronger stimulator of phagocytes than P. gingivalis (44, 45, 46, 47) . A. actinomycetemcomitans LPS is inducing higher amounts of IL-1β, TNF-α and IL-8 in PMNs than P. gingivalis LPS (48), evoking a more acute, E.coli -like inflammatory immune response. This might help explaining the severe and relative early onset of periodontal breakdown associated with A.
actinomycetemcomitans infection, especially in patients with aggressive periodontitis (49) .
An interesting aspect of the periodontal pathogen P. gingivalis is its capability to produce bacterial cysteine proteinases (gingipains) which are able to proteolyse human monocyte mCD14 (50, 51) . However, protease inhibitors present in serum inhibit the gingipain activity (51), since in our bacterial stimulation assays A. actinomycetemcomitans and P.
gingivalis were similarly able to induce mCD14 upregulation on monocytes, although of different amplitude.
In conclusion, we suggest that receptor expression patterns by monocytes may be related to the susceptibility of a subject to become infected with certain periodontal pathogens. The enrichment of the FcγRIII + monocytes in periodontitis, in particular in patients that are culture-positive for P. gingivalis, may result in formation of a dendritic cell type that can stimulate T cells less efficiently. As monocytes and their progeny, the dendritic cells, are expected to orchestrate the immune response in periodontitis, the
